1. Anderson JE, Appelbaum FR, Deeg HJ, Storb R. Phase II study of busulfan (busulfan) and total body irradiation (TBI) as a novel preparative regimen in allogeneic marrow transplantation (BMT) for advanced myelodysplastic syndrome [abstract].Leuk Res. 1999:23.
2. Anderson JE. Allogeneic hematopoietic cell transplantation for myelodysplastic and myeloproliferative disorders. In: Hematopoietic Cell transplantation, 2nd ed. (Thomas ED, Blume KG, Forman SJ, eds.), Blackwell Science, Inc., Malden, MA. 1999:872–886.
3. Appelbaum FR, Anderson J. Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcome analysis according to IPSS score.Leukemia. 1998;12(suppl 1):S25-S29.
4. Aul C, Gattermann N, Schneider W. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes.Br J Haematol. 1992;82:358–367.
5. Barrett J, Saunthararajah Y, Molldrem J. Myelodysplastic syndrome and aplastic anemia: Distinct entities or diseases linked by a common pathophysiology?Sem in Hema. 2000;37:15–29.